<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>TRICARE Coverage of National Institute of Allergy and Infectious Disease Coronavirus Disease 2019 Clinical Trials</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <style>
        body { font-family: Arial, sans-serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { color: #333; }
        .metadata { color: #666; font-size: 0.9em; }
        .summary { margin-top: 20px; line-height: 1.5; }
        .source { margin-top: 20px; }
    </style>
</head>
<body>
    <h1>TRICARE Coverage of National Institute of Allergy and Infectious Disease Coronavirus Disease 2019 Clinical Trials</h1>
    <div class="metadata">Published: 2026-02-05 12:26:03</div>
    <div class="summary">The Assistant Secretary of Defense for Health Affairs (ASD(HA)) issues this interim final rule (IFR) with request for comments to temporarily modify the TRICARE regulation by adding coverage for National Institute of Allergy and Infectious Disease (NIAID)-sponsored clinical trials for the treatment or prevention of coronavirus disease 2019 (COVID-19).</div>
    <div class="source">Source: <a href="https://www.federalregister.gov/documents/2020/10/30/2020-24114/tricare-coverage-of-national-institute-of-allergy-and-infectious-disease-coronavirus-disease-2019" target="_blank" rel="noopener noreferrer">https://www.federalregister.gov/documents/2020/10/30/2020-24114/tricare-coverage-of-national-institute-of-allergy-and-infectious-disease-coronavirus-disease-2019</a></div>
</body>
</html>
